Articles: function.
-
Interstitial Lung Disease CasesSESSION TYPE: Case ReportsPRESENTED ON: Saturday, March 22, 2014 at 09:00 AM - 10:00 AMINTRODUCTION: A Niemann-Pick disease is caused by sphingomyelinase deficiency resulting in the accumulation of sphingomyelin in various cell types. Prognosis varies in accordance with organ involvement. The case presented relates to subtype B, characterized by visceral involvement and no neurological deficit. ⋯ The following authors have nothing to disclose: Ines Sanches, Cidália Rodrigues, Fátima Teixeira, Yvette MartinsNo Product/Research Disclosure Information.
-
COPD Epidemiology & Physiology PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: The aim of our study was to evaluated the capacity of NT-proBNP to identify high risk patients with COPD exacerbations. ⋯ The following authors have nothing to disclose: Elena Garcia Castillo, Tamara Alonso Pérez, Gonzalo Segrelles Calvo, Olga Rajas Naranjo, Enrique Zamora García, Julio AncocheaNo Product/Research Disclosure Information.
-
Cardiovascular Case Report Posters IISESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Lyme disease is a tick-borne illness caused by spirochete Borrelia Burgdorferi. Cardiac manifestations of Lyme disease mostly include conduction abnormalities which occur weeks to a few months after the onset of infection. ⋯ Lyme Carditis should be suspected as the cause of AV conduction block in the setting of a travel history to Lyme endemic area and Erythema Migrans rash, with or without the history of a tick bite.Reference #1: N/ADISCLOSURE: The following authors have nothing to disclose: Sameer Chadha, Geurys Rojas Marte, Bernard Topi, Gerald Hollander, Jacob ShaniNo Product/Research Disclosure Information.
-
BronchiectasisSESSION TYPE: Slide PresentationsPRESENTED ON: Saturday, March 22, 2014 at 09:00 AM - 10:00 AMPURPOSE: Evaluation of morbidity and risk factors for mortality in hospitalized patients with acute exacerbation of bronchiectasis. ⋯ The following authors have nothing to disclose: Maria João Oliveira, Daniel Vaz, Daniel Coutinho, Margarida Dias, Maria do Céu BritoNo Product/Research Disclosure Information.
-
Pulmonary Hypertension Posters IISESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: The prevalence of PAH in patients with IPF is not well known. There has been no prospective study to date. The purpose of our study was to know the prevalence of PAH in patients with IPF at any stage of severity ⋯ 60 patients (18 women, age at diagnosis 64 years) were included and 56 completed the study protocol. Patient characteristics: FVC 64%, DLCO 41%, 6MWT 357 meters, systolic pulmonary arterial pressure 46 mmHg. 17 patients showed a systolic pulmonary artery pressure greater than 40 mmHg and in 14 of them PAH was confirmed by right heart catheterization with a mean pulmonary arterial pressure of 28.6 mmHg. When comparing various clinical and functional parameters between patients with and without PAH significant differences were seen in FVC, FEV1, DLCO, 6MWT and Functional Class. In a multivariate analysis DLCO was associated with the presence of PAHCONCLUSIONS: PAH is not infrequent in patients with IPF (around 26%).Patients with more severe disease are more likely to develop PAH. A marked decrease in DLCO is independently associated with the presence of PAHCLINICAL IMPLICATIONS: PAH is a devastating disease with prognostic and therapeutic implications in patients with IPF. To know the prevalence and associated factors in very important for a better management of this patients because we now have effective treatments in PAHDISCLOSURE: The following authors have nothing to disclose: Adolfo Villar, Julio Ancochea, Antonio XaubetNo Product/Research Disclosure Information.